CAC
SGMO

Certified Advisory Corp’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Certified Advisory Corp’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$1K Hold
120
– – ﹤0.01% 733
2020
Q1 		$1K Hold
120
– – ﹤0.01% 744
2019
Q4 		$1K Hold
120
– – ﹤0.01% 772
2019
Q3 		$1K Hold
120
– – ﹤0.01% 769
2019
Q2 		$1K Hold
120
– – ﹤0.01% 778
2019
Q1 		$1K Hold
120
– – ﹤0.01% 723
2018
Q4 		$1K Hold
120
– – ﹤0.01% 717
2018
Q3 		$2K Buy
120
+60
+100% +$912 ﹤0.01% 721
2018
Q2 		$1K Buy
+60
New +$997 ﹤0.01% 742

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Certified Advisory Corp's SGMO Position: Q2 2020 in Review

Certified Advisory Corp held its SANGAMO THERAPEUTICS INC (SGMO) position steady in Q2 2020 at 120 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #733.

Certified Advisory Corp first reported a position in SGMO in Q2 2018 and has held it in 9 quarters since. The position peaked at $2K in Q3 2018. 205 funds tracked by Wall St. Rank hold SGMO as of Q2 2020.

  • Certified Advisory Corp held 120 shares of SANGAMO THERAPEUTICS INC worth $1K as of Q2 2020.
  • Certified Advisory Corp left its SANGAMO THERAPEUTICS INC share count unchanged in Q2 2020.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Certified Advisory Corp's portfolio in Q2 2020, its #733 holding.
  • Certified Advisory Corp first reported a position in SANGAMO THERAPEUTICS INC in Q2 2018 and has held it in 9 quarters since.
  • Certified Advisory Corp's SANGAMO THERAPEUTICS INC position peaked at $2K in Q3 2018.
  • 205 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2020.

Based on Certified Advisory Corp's 13F filing for Q2 2020, filed 27 Jul 2020.